On Wednesday 9th March 2022, Dr Patrick Harrison (Head of the Cystic Fibrosis Gene Editing group, Department of Physiology, UCC), was invited to Leinster House to give evidence on the use of CRISPR-Cas9 as therapeutic tool to study and treat genetic disorders.

The Irish Examiner runs an occasional column called Working Life featuring a snapshot of the daily life of people in different jobs. This month, the column featured Dr Patrick Harrison who heads the Cystic Fibrosis Gene Editing Group in the Physiology Department at UCC.